Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
Next >
Expert Ratings for Biomarin Pharmaceutical
August 04, 2022
Tickers
BMRN
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
BioMarin Lifts Annual Guidance On Better Than Expected Q2 Earnings
August 04, 2022
Tickers
BMRN
Tags
Market News
General
Pre/Market Outlook
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
KTRA
ARQT
RHHBY
From
Benzinga
These eight health-care stocks can keep you invested in the market with less worry
August 02, 2022
Tickers
BIIB
BMRN
BMY
MEDP
Tags
SGEN
TMO
MEDP
From
MarketWatch
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
Tickers
AFMD
BMRN
CRSP
EXEL
Tags
MRNA
Market News
IONS
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
July 13, 2022
Tickers
ABEV
ALNY
ANET
ATRA
Tags
ECL
ALNY
ROL
From
Benzinga
Analyst Ratings for Biomarin Pharmaceutical
July 13, 2022
Tickers
BMRN
Tags
BMRN
BZI/AAR
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Tickers
APLS
ATHA
BMRN
CBIO
Tags
ENTA
biotech sector
Movers
From
Benzinga
What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical
June 13, 2022
Tickers
BMRN
Tags
Benzinga
Market News
BMRN
From
Benzinga
Is Now the Time to Buy This Risky Stock With Huge Upside Potential?
June 04, 2022
Tickers
BMRN
CPRX
Tags
BMRN
CPRX
Market News
From
Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2022
Tickers
ALGN
BCRX
BMRN
BMY
Tags
Options
BZI/AUOA
BMRN
From
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Tickers
ADMA
ALT
BHC
BMRN
Tags
OSUR
ALT
MREO
From
Benzinga
BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy
April 28, 2022
Tickers
AMGN
BMRN
Tags
Market News
General
AMGN
From
Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Tickers
ACHV
ALKS
ALLO
AMGN
Tags
MOH
VKTX
SLDB
From
Benzinga
Biomarin Pharmaceutical Earnings Preview
April 26, 2022
Tickers
BMRN
Tags
Benzinga
Earnings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
April 25, 2022
Tickers
A
ABR
AGNC
ALNY
Tags
STRY
HOLX
CRL
From
Benzinga
10 Biggest Price Target Changes For Monday
April 25, 2022
Tickers
AMAT
AVY
BMRN
CRL
Tags
BMRN
WDAY
CRL
From
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Tickers
ABBV
ALKS
ALNY
AMGN
Tags
IBB
FDA
OCUP
From
Benzinga
A Bearish Sign Appears On Biomarin Pharmaceutical's Chart
April 21, 2022
Tickers
BMRN
Tags
BMRN
Movers
Benzinga
From
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Tickers
ALNY
AMGN
AZN
BIIB
Tags
AZN
BIIB
SRPT
From
InvestorPlace
Why BioMarin Pharmaceutical Tumbled on Thursday
February 24, 2022
Tickers
BMRN
Tags
BMRN
Market News
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
EBS
ADGI
General
From
Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
Tickers
BMRN
SNY
Tags
Guidance
BMRN
News
From
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 23, 2022
Tickers
BMRN
Tags
Market News
Earnings
Benzinga
From
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Tickers
AKBA
ARNA
AVNS
BHC
Tags
BMRN
News
Penny Stocks
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
CDXS
FDA
IOVA
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
Biotech
Health Care
Benzinga
From
Benzinga
BioMarin Sells Priority Review Voucher For $110M
February 09, 2022
Tickers
BMRN
Tags
Health Care
Benzinga
Biotech
From
Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
Tickers
ADGI
ALLK
ALNY
ARGX
Tags
DNLI
ALLK
ALNY
From
MarketWatch
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
News
BMRN
Briefs
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.